학술논문
IDF2022-0602 Metformin or SGLT2 inhibitor as 1st line treatment of type 2 diabetes? Design and interim results of the SMARTEST trial
Document Type
Abstract
Author
Source
In Diabetes Research and Clinical Practice March 2023 197 Supplement 1
Subject
Language
ISSN
0168-8227